When Will Payers Improve Coverage of Prescription Digital Therapeutics?
Published: | Updated:
New MMIT research highlights payers’ continued hesitancy toward PDTs. Here’s what manufacturers need to know.
Jayne Hornung
Advertisement
Chief clinical officer, MMIT (Managed Markets Insight & Technology).
Articles by Jayne Hornung
Advertisement
Latest Updated Articles
When Will Payers Improve Coverage of Prescription Digital Therapeutics?Published: July 22nd 2022 | Updated: February 13th 2025
Advertisement
Advertisement
Trending on PharmExec
1
Technological Renaissance: AI’s Integration into the Pharmaceutical Industry
2
FDA's History with Complex Plants
3
Novo Nordisk Invests $506 Million in Ireland Manufacturing Facility Expansion
4
Patent Term Extension: Challenges with Defining and Claiming Approved Biologics
5